Literature DB >> 23714418

Major depression after withdrawing dopamine agonists in two patients with restless legs syndrome and impulse control disorders.

Claire Launois, Smaranda Leu-Semenescu, Agnès Brion, Isabelle Arnulf.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23714418     DOI： 10.1016/j.sleep.2013.04.009

Source DB:  PubMed          Journal:  Sleep Med        ISSN： 1389-9457            Impact factor:   3.492


× No keyword cloud information.
  2 in total

1.  Dopamine agonist withdrawal syndrome in a patient with restless legs syndrome without impulse control disorder or drug abuse.

Authors:  Yasushi Shimo; Asuka Nakajima; Nobutaka Hattori
Journal:  Neurol Sci       Date:  2014-11-02       Impact factor: 3.307

2.  Increased Risk for New-Onset Psychiatric Adverse Events in Patients With Newly Diagnosed Primary Restless Legs Syndrome Who Initiate Treatment With Dopamine Agonists: A Large-Scale Retrospective Claims Matched-Cohort Analysis.

Authors:  Cheryl Hankin; Daniel Lee; Diego Garcia-Borreguero; Zhaohui Wang
Journal:  J Clin Sleep Med       Date:  2019-09-15       Impact factor: 4.062
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.